Global X Scientific Beta US ETF (SCIU) is an exchange-traded fund that seeks to correspond to the price and yield performance, before fees and expenses, of the Scientific Beta United States Multi-Beta Multi-Strategy Index. The fund invests at least 80% of its total assets in securities comprising the underlying index, which selects and weights approximately 500 or fewer U.S.-listed large- and mid-cap stocks using multiple scientific beta factors including value, momentum, low volatility, and quality; it emphasizes diversified multi-factor exposure to enhance risk-adjusted returns relative to traditional market-cap weighted benchmarks. SCIU provides investors with exposure to U.S. equities across sectors such as technology, financials, healthcare, and consumer discretionary, targeting institutional and retail investors seeking smart beta strategies.
Launched in May 2015 and issued by Global X Management Company LLC, a subsidiary of Mirae Asset Global Investments headquartered in New York, New York, the ETF operates primarily in the U.S. market with assets under management of approximately $22-25 million as of late 2025. The fund is part of Global X's broader lineup of thematic and factor-based ETFs, leveraging indices developed by Scientific Beta, a smart beta index provider acquired by Singapore Exchange (SGX) in 2020.
In recent developments, SCIU has demonstrated outperformance relative to its benchmarks, with the full suite of Global X Scientific Beta ETFs surpassing their respective indices as of year-end 2024, driven by effective multi-factor allocation amid volatile markets. The ETF continues to attract inflows, including a notable 28.2% unit increase in one reported period, reflecting sustained investor interest in its low-volatility, diversified approach. No major closures, liquidations, or strategic shifts specific to SCIU have occurred in the last 1-2 years, unlike certain other Global X products, with ongoing distributions supporting its yield of around 3.3%.